NEW YORK (GenomeWeb News) — Tripos has entered into a material agreement to sell its Discovery Research business to Commonwealth Biotechnologies, according to a term sheet Tripos filed on April 20 with the US Securities and Exchange Commission.
 
CBI, a molecular diagnostics company based in Richmond, Va., would pay as much as $2.3 million for the unit, broken down into $500,000 in cash and a total of $1.8 million in base receivables. The term sheet expires in early May.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.